# A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease

Study · id `cardio:ct-nct03941314` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03941314](<https://clinicaltrials.gov/study/NCT03941314>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03941314

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

## Technical summary

Registry record NCT03941314. Randomized; no masking; primary purpose treatment. Start 2019-06-25 (actual); primary completion 2026-03-19 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 300 participants (enrolled count; ClinicalTrials.gov record NCT03941314, source copy `cardio:ctgov-nct03941314-2026-06-12`, retrieved 2026-10-31)
- Started: 2019-06-25 (actual) (ClinicalTrials.gov record NCT03941314, source copy `cardio:ctgov-nct03941314-2026-06-12`, retrieved 2026-10-31)
- Primary completion: 2026-03-19 (actual) (ClinicalTrials.gov record NCT03941314, source copy `cardio:ctgov-nct03941314-2026-06-12`, retrieved 2026-10-31)
- Completion: 2026-03-19 (actual) (ClinicalTrials.gov record NCT03941314, source copy `cardio:ctgov-nct03941314-2026-06-12`, retrieved 2026-10-31)
- Countries: Spain; Switzerland (ClinicalTrials.gov record NCT03941314, source copy `cardio:ctgov-nct03941314-2026-06-12`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03941314-2026-06-12`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease
- Condition: Peripheral Arterial Disease
- Intervention (Device): Supera® Peripheral Stent System
- Intervention (Device): EverFlex™ Self-Expanding Peripheral Stent System
- Lead sponsor: Kantonsspital Winterthur KSW
- Lead sponsor class: OTHER
- Collaborator: Abbott
- Collaborator class: INDUSTRY
- Collaborator: Cantonal Hospital of St. Gallen
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)

## Provenance

Content hash: 16e6a0642ba8ba9c91088088cf343cc39f3622e6590d61e3528b46f06305cc1b
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
